|
2013 Conference Publication The role of macrophages in docetaxel (DTX) resistance in castrate-resistant prostate cancer (CRPC)Horvath, Lisa, Chatfield, Mark D., Lee-Ng, Michelle, Lin, Hui-Ming, Castillo, Lesley, Breit, Samuel N., Brown, David A., Molloy, Mark P., Marx, Gavin M., Pavlakis, Nick, Boyer, Michael J., Stockier, Martin R., Wykes, Richard, Henshall, Susan M. and Mahon, Kate Lynette (2013). The role of macrophages in docetaxel (DTX) resistance in castrate-resistant prostate cancer (CRPC). 49th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Chicago Il, May 31-Jun 04, 2013. PHILADELPHIA: LIPPINCOTT WILLIAMS & WILKINS. |
|
2013 Journal Article Health-related quality of life and inflammatory markers in malignant pleural mesotheliomaKao, Steven C., Vardy, Janette, Harvie, Rozelle, Chatfield, Mark, van Zandwijk, Nico, Clarke, Stephen and Pavlakis, Nick (2013). Health-related quality of life and inflammatory markers in malignant pleural mesothelioma. Supportive Care in Cancer, 21 (3), 697-705. doi: 10.1007/s00520-012-1569-6 |
|
2013 Journal Article Iron status is inversely associated with dietary iron intakes in patients with inactive or mildly active inflammatory bowel diseasePowell, Jonathan J., Cook, William B., Chatfield, Mark, Hutchinson, Carol, Pereira, Dora I. A. and Lomer, Miranda C. E. (2013). Iron status is inversely associated with dietary iron intakes in patients with inactive or mildly active inflammatory bowel disease. Nutrition & Metabolism, 10 (1) 18. doi: 10.1186/1743-7075-10-18 |
|
2013 Journal Article Dietary fortificant iron intake is negatively associated with quality of life in patients with mildly active inflammatory bowel diseasePowell, Jonathan J., Cook, William B., Hutchinson, Carol, Tolkien, Zoe, Chatfield, Mark, Pereira, Dora I. A. and Lomer, Miranda C. E. (2013). Dietary fortificant iron intake is negatively associated with quality of life in patients with mildly active inflammatory bowel disease. Nutrition & Metabolism, 10 (1) 9. doi: 10.1186/1743-7075-10-9 |
|
2013 Conference Publication A single dose of azithromcyin did not improve clinical outcomes in children ≤ 18 months hospitalized with acute bronchiolitis: a double-blind, placebo-controlled randomized trialMccallum, G., Morris, P. S., Chatfield, M. D., Maclennan, C., White, A., Versteegh, L., Wilson, C., Jacobsen, N. and Chang, A. B. (2013). A single dose of azithromcyin did not improve clinical outcomes in children ≤ 18 months hospitalized with acute bronchiolitis: a double-blind, placebo-controlled randomized trial. Thoracic Society of Australia & New Zealand and the Australian & New Zealand Society of Respiratory Science 2013 Annual Scientific Meetings, Darwin, NT, Australia, 22-27 March 2013. Richmond, VIC, Australia: Wiley-Blackwell Publishing. doi: 10.1111/resp.12046 |
|
2013 Journal Article Human papillomavirus modifies the prognostic significance of T stage and possibly N stage in tonsillar cancerHong, A. M., Martin, A., Armstrong, B. K., Lee, C. S., Jones, D., Chatfield, M. D., Zhang, M., Harnett, G., Clark, J., Elliott, M., Milross, C., Smee, R., Corry, J., Liu, C., Porceddu, S., Vaska, K., Veness, M., Morgan, G., Fogarty, G., Veivers, D., Rees, G. and Rose, B. (2013). Human papillomavirus modifies the prognostic significance of T stage and possibly N stage in tonsillar cancer. Annals of Oncology, 24 (1) mds205, 215-219. doi: 10.1093/annonc/mds205 |
|
2013 Journal Article Validation of prognostic factors in malignant pleural mesothelioma: a retrospective analysis of data from patients seeking compensation from the New South Wales dust diseases boardKao, Steven C., Vardy, Janette, Chatfield, Mark, Corte, Peter, Pavlakis, Nick, Clarke, Christopher, van Zandwijk, Nico and Clarke, Stephen (2013). Validation of prognostic factors in malignant pleural mesothelioma: a retrospective analysis of data from patients seeking compensation from the New South Wales dust diseases board. Clinical Lung Cancer, 14 (1), 70-77. doi: 10.1016/j.cllc.2012.03.011 |
|
2012 Journal Article Electroacupuncture for nausea, vomiting, and myelosuppression in women receiving adjuvant chemotherapy for early breast cancer: a randomized controlled pilot trialBeith, Jane M., Oh, Byeongsang, Chatfield, Mark D., Davis, Esther and Venkateswaran, Ramya (2012). Electroacupuncture for nausea, vomiting, and myelosuppression in women receiving adjuvant chemotherapy for early breast cancer: a randomized controlled pilot trial. Medical Acupuncture, 24 (4), 241-248. doi: 10.1089/acu.2012.0876 |
|
2012 Journal Article Dietary iron is associated with memory in midlife: longitudinal cohort studyRickard, Anna P., Chatfield, Mark D., Powell, Jonathan J., Stephen, Alison M. and Richards, Marcus (2012). Dietary iron is associated with memory in midlife: longitudinal cohort study. Journal of Pharmacy and Nutrition Sciences, 2 (1), 57-62. doi: 10.6000/1927-5951.2012.02.01.8 |
|
2012 Journal Article Definitive radiotherapy or chemoradiotherapy in the treatment of Merkel cell carcinomaSundaresan, P., Hruby, G., Hamilton, A., Hong, A., Boyer, M., Chatfield, M. and Thompson, J. F. (2012). Definitive radiotherapy or chemoradiotherapy in the treatment of Merkel cell carcinoma. Clinical Oncology, 24 (9), E131-E136. doi: 10.1016/j.clon.2012.04.007 |
|
2012 Journal Article Antibiotics for bronchiectasis exacerbations in children: Rationale and study protocol for a randomised placebo-controlled trialChang, Anne B., Grimwood, Keith, Robertson, Colin F., Wilson, Andrew C., van Asperen, Peter P., O'Grady, Kerry-Ann F., Sloots, Theo P., Torzillo, Paul J., Bailey, Emily J., Mccallum, Gabrielle B., Masters, Ian B., Byrnes, Catherine .A, Buntain, Helen M., Morris, Peter S., Mackay, Ian M. and Chatfield, Mark D. (2012). Antibiotics for bronchiectasis exacerbations in children: Rationale and study protocol for a randomised placebo-controlled trial. Trials, 13 (156) 156, 156-1-156-9. doi: 10.1186/1745-6215-13-156 |
|
2012 Journal Article High Gleason grade carcinoma at a positive surgical margin predicts biochemical failure after radical prostatectomy and may guide adjuvant radiotherapySavdie, Richard, Horvath, Lisa G., Benito, Ruth Pe, Rasiah, Krishan K., Haynes, Anne-Maree, Chatfield, Mark, Stricker, Phillip D., Turner, Jennifer J., Delprado, Warwick, Henshall, Susan M., Sutherland, Robert L. and Kench, James G. (2012). High Gleason grade carcinoma at a positive surgical margin predicts biochemical failure after radical prostatectomy and may guide adjuvant radiotherapy. BJU International, 109 (12), 1794-1800. doi: 10.1111/j.1464-410X.2011.10572.x |
|
2012 Conference Publication Progression-free survival (PFS) as a surrogate end point for overall survival (OS) in first-line treatment of advanced epithelial ovarian cancer (EOC)Sjoquist, Katrin Marie, Lee, Chee, Lord, Sally, Chatfield, Mark D., Friedlander, Michael, Simes, John and Marschner, Ian (2012). Progression-free survival (PFS) as a surrogate end point for overall survival (OS) in first-line treatment of advanced epithelial ovarian cancer (EOC). 48th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Chicago Il, Jun 01-06, 2012. ALEXANDRIA: AMER SOC CLINICAL ONCOLOGY. |
|
2012 Conference Publication EVERSUN: A phase II trial of everolimus alternating with sunitinib as first-line therapy for advanced renal cell carcinoma (RCC) (ANZUP trial 0901)Davis, Ian D., Gebski, Val, Chatfield, Mark D., Grimison, Peter S., Kannourakis, George, Boland, Amy L., Thompson, Jennifer and Stockler, Martin R. (2012). EVERSUN: A phase II trial of everolimus alternating with sunitinib as first-line therapy for advanced renal cell carcinoma (RCC) (ANZUP trial 0901). 48th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Chicago Il, Jun 01-06, 2012. ALEXANDRIA: AMER SOC CLINICAL ONCOLOGY. |
|
2012 Journal Article HDR brachytherapy combined with external beam radiation for localised prostate cancer: early experience from the Sydney Cancer CentreWhalley, Deborah, Patanjali, Nitya, Jackson, Michael, Lovett, Aimee, Chatfield, Mark and Hruby, George (2012). HDR brachytherapy combined with external beam radiation for localised prostate cancer: early experience from the Sydney Cancer Centre. Journal of Medical Imaging and Radiation Oncology, 56 (2), 220-226. doi: 10.1111/j.1754-9485.2012.02358.x |
|
2012 Conference Publication Accelerated BEP for metastatic germ cell tumors: Combined analysis of Australian and UK phase I/II trialsGrimison, Peter S., Chatfield, Mark D., Mazhar, Danish, Toner, Guy C., Chester, John D., Stockler, Martin R., Stark, Daniel P., Thomson, Damien B., Shamash, Jonathan, Friedlander, Michael, White, Jeff, Gebski, Val, Wason, James, Boland, Amy L., Rimmer, Yvonne L., McDonald, Angus, Gurney, Howard, Rosenthal, Mark, Singhal, Nimit and Williams, Michael V. (2012). Accelerated BEP for metastatic germ cell tumors: Combined analysis of Australian and UK phase I/II trials. 48th Annual Meeting of the American Society of Clinical Oncology (ASCO), Chicago, Il United States, 01-06 June 2012. Alexandria, VA United States: American Society of Clinical Oncology. |
|
2011 Journal Article Low Calretinin Expression and High Neutrophil-To-Lymphocyte Ratio Are Poor Prognostic Factors in Patients with Malignant Mesothelioma Undergoing Extrapleural PneumonectomyKao, Steven Chuan-Hao, Klebe, Sonja, Henderson, Douglas W., Reid, Glen, Chatfield, Mark, Armstrong, Nicola J., Yan, Tristan D., Vardy, Janette, Clarke, Stephen, van Zandwijk, Nico and McCaughan, Brian (2011). Low Calretinin Expression and High Neutrophil-To-Lymphocyte Ratio Are Poor Prognostic Factors in Patients with Malignant Mesothelioma Undergoing Extrapleural Pneumonectomy. Journal of Thoracic Oncology, 6 (11), 1923-1929. doi: 10.1097/JTO.0b013e31822a3740 |
|
2011 Conference Publication CALRETININ EXPRESSION IMPROVES THE PREDICTIVE ACCURACY IN SURVIVAL IN PATIENTS WITH MALIGNANT PLEURAL MESOTHELIOMA (MPM) UNDERGOING EXTRAPLEURAL PNEUMONECTOMY (EPP)Kao, Steven C., Klebe, Sonja, Henderson, Douglas W., Reid, Glen, Chatfield, Mark, Armstrong, Nicola, Yan, Tristan, Vardy, Janette, Clarke, Stephen, Van Zandwijk, Nico and Mccaughan, Brian (2011). CALRETININ EXPRESSION IMPROVES THE PREDICTIVE ACCURACY IN SURVIVAL IN PATIENTS WITH MALIGNANT PLEURAL MESOTHELIOMA (MPM) UNDERGOING EXTRAPLEURAL PNEUMONECTOMY (EPP). PHILADELPHIA: LIPPINCOTT WILLIAMS & WILKINS. |
|
2011 Conference Publication MARKERS OF PROGNOSIS IN RESECTED STAGE IB NON-SMALL CELL LUNG CANCER (NSCLC)Yip, Po Yee, Cooper, Wendy, Mahar, Annabelle, Kench, James, Kohonen-Corish, Maija R. J., Chatfield, Mark, Boulghourjian, Alice, Kennedy, Catherine W., Mccaughan, Brian, Boyer, Michael and Horvath, Lisa (2011). MARKERS OF PROGNOSIS IN RESECTED STAGE IB NON-SMALL CELL LUNG CANCER (NSCLC). PHILADELPHIA: LIPPINCOTT WILLIAMS & WILKINS. |
|
2011 Conference Publication PROGNOSTIC FACTORS IN MALIGNANT PLEURAL MESOTHELIOMA (MPM) IN A COHORT OF PATIENTS COMPENSATED BY THE DUST DISEASES BOARDKao, Steven C., Clarke, Stephen, Chatfield, Mark, Corte, Peter, Clarke, Christopher, Vardy, Janette and Van Zandwijk, Nico (2011). PROGNOSTIC FACTORS IN MALIGNANT PLEURAL MESOTHELIOMA (MPM) IN A COHORT OF PATIENTS COMPENSATED BY THE DUST DISEASES BOARD. PHILADELPHIA: LIPPINCOTT WILLIAMS & WILKINS. |
